Edwards Lifesciences Corporation (EW) vs Koninklijke Philips N.V. (PHG)
Edwards Lifesciences Corporation and Koninklijke Philips N.V. are both Medical Devices companies. Edwards Lifesciences Corporation is the larger, with a market value of $49.4B against $24.0B — 2.1× the size. Koninklijke Philips N.V. trades at the lower P/E: 18.2× against 49.6×. Edwards Lifesciences Corporation grew revenue faster over the last twelve months: 14.6% against 9.11%. Edwards Lifesciences Corporation has the higher net margin (15.4% vs 6.24%) and the higher return on invested capital (12.8% vs 6.69%). Across the 22 metrics below, Edwards Lifesciences Corporation leads on 12 and Koninklijke Philips N.V. on 10.
Valuation
Profitability
| Metric | EW | PHG | Medical Devices median |
|---|---|---|---|
| Gross margin | 77.84% | 45.93% | 56.01% |
| Operating margin | 22.25% | 9.64% | (15.03%) |
| Net margin | 15.43% | 6.24% | (20.40%) |
| Free cash flow margin | 22.01% | 8.99% | (7.24%) |
| Return on equity | 9.42% | 10.20% | (15.32%) |
| Return on assets | 7.35% | 4.21% | (19.72%) |
| Return on invested capital | 12.81% | 6.69% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack